Results 131 to 140 of about 13,220 (219)

Will Ceftazidime-Avibactam Replace Polymyxins in Asia?

Clinical Infectious Diseases, 2021
Sock Hoon, Tan, Narendran, Koomanan, Shimin Jasmine, Chung, Andrea Lay-Hoon, Kwa   +3 more
openaire   +2 more sources

Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]

Infect Drug Resist
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc   +1 more source

What every intensivist should know about the management of peritonitis in the intensive care unit [PDF]

, 2018
De Waele, Jan
core   +2 more sources

Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]

Am J Case Rep
Nuaimi M, Cirillo J, Usbosy S, Egan D, Kovacich A, Madruga M, Carlan SJ.   +6 more
europepmc   +1 more source

Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. [PDF]

Eur J Hosp Pharm
Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T.   +5 more
europepmc   +1 more source

Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum β-lactamases in the UK: relatedness and resistance [PDF]

, 2018
Greenwood, Beckie, Hill, Robert, Hopkins, Katie L, Ivanov, Zdravko, Livermore, David M, Meunier, Danièle, Pike, Rachel, Turton, Jane F, Woodford, Neil   +8 more
core   +1 more source

Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. [PDF]

Microbiol Spectr
Sandstrom TS, Banete A, Kanyua A, Davis KM, Poutanen SM.   +4 more
europepmc   +1 more source

Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]

BMC Microbiol
Huang M, Xiao SP, Zeng QH, Guo HM, Liu YT, Wei DD, Kang XH.   +6 more
europepmc   +1 more source

Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]

Pathogens
Vougiouklakis G, Tsioutis C, Vasileiadi N, Alexakis K, Spernovasilis N, Agouridis AP.   +5 more
europepmc   +1 more source

Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China. [PDF]

Front Cell Infect Microbiol
Qin X, Xiang T, Zhang X, Ma X, Zhao W, Yu Y, Zhao C, Gao L, Li L, Wang T, Pang C, Zhao X, Han R, Cao F, Su M, Lu J, Xu W, Yin S, Lu D, Yang X, Wang M.   +20 more
europepmc   +1 more source